Abstract
Objective:
To compare the concentrations of cytokines belonging to Th17 axis (interleukin (IL)-17 and IL-23) and Th1 axis (IL-12 and interferon (IFN)-γ) in obese and lean women, and to investigate their relationships with the proinflammatory adipokine leptin, proinflammatory cytokine macrophage migration inhibitory factor (MIF) and anthropometric and metabolic parameters of obesity.
Design:
Cross-sectional study.
Subjects:
Twenty-six obese women (age 20–52 years, body mass index (BMI): 30–48 kg/m2) and 20 healthy lean women (age 23–46 years, BMI: 18–25 kg/m2).
Measurements:
Plasma levels of cytokines and leptin, BMI, waist circumference (WC) and insulin resistance index HOMA (homeostatic model assessment).
Results:
Blood concentrations of IL-17, IL-23, MIF and leptin, but not IL-12 or IFN-γ, were higher in obese compared with lean women (P=0.002, 0.046, 0.006 and 0.002, respectively). There was a positive correlation between IL-17 and IL-23 (rs=0.530), which was at the border of statistical significance (P=0.065). Neither IL-17 nor IL-23 correlated with leptin or MIF, and there was no association between IL-17 and IL-23 levels with BMI, WC or HOMA index.
Conclusion:
Interleukin-23/IL-17 axis is stimulated in obese women independently of the increase in abdominal fat, insulin resistance, leptin and MIF levels.
Similar content being viewed by others
References
Hotamisligil GS, Shargill NS, Spiegelman BM . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91.
Dandona P, Aljada A, Bandyopadhyay A . Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25: 4–7.
Shoelson SE, Herrero L, Naaz A . Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132: 2169–2180.
Hansson GK, Robertson AK, Soderberg-Naucler C . Inflammation and atherosclerosis. Annu Rev Pathol 2006; 1: 297–329.
Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ . Cardiovascular metabolic syndrome—an interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab 2007; 9: 218–232.
Anderson EJ, McGrath MA, Thalhamer T, McInnes IB . Interleukin-12 to interleukin ‘infinity’: the rationale for future therapeutic cytokine targeting. Springer Semin Immunopathol 2006; 27: 425–442.
Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ . IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004; 202: 96–105.
Miljkovic D, Trajkovic V . Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev 2004; 15: 21–32.
Hunter CA . New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005; 5: 521–531.
Pacifico L, Di Renzo L, Anania C, Osborn JF, Ippoliti F, Schiavo E et al. Increased T-helper interferon-gamma-secreting cells in obese children. Eur J Endocrinol 2006; 154: 691–697.
Palacio A, Lopez M, Perez-Bravo F, Monkeberg F, Schlesinger L . Leptin levels are associated with immune response in malnourished infants. J Clin Endocrinol Metab 2002; 87: 3040–3046.
Svec P, Vasarhelyi B, Paszthy B, Korner A, Kovacs L, Tulassay T et al. Do regulatory T cells contribute to Th1 skewness in obesity? Exp Clin Endocrinol Diabetes 2007; 115: 439–443.
Church TS, Willis MS, Priest EL, Lamonte MJ, Earnest CP, Wilkinson WJ et al. Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes (Lond) 2005; 29: 675–681.
Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D et al. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 2004; 89: 5043–5047.
Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P . Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004; 110: 1564–1571.
Sakaue S, Ishimaru S, Hizawa N, Ohtsuka Y, Tsujino I, Honda T et al. Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity. Int J Obes (Lond) 2006; 30: 238–242.
Lago F, Dieguez C, Gómez-Reino J, Gualillo O . The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007; 18: 313–325.
Liu L, Yang P, He H, Lin X, Jiang L, Chi W et al. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion. Br J Ophthalmol 2008; 92: 557–561.
Stojanovic I, Cvjeticanin T, Lazaroski S, Stosic-Grujicic S, Miljkovic D . Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells. Immunology 2008; (in press) DOI 10.1111/j.1365-2567.2008.02879.x.
Larson DF, Horak K . Macrophage migration inhibitory factor: controller of systemic inflammation. Crit Care 2006; 10: 138.
Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL . Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278: 1910–1914.
Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H et al. Production and functions of IL-17 in microglia. J Neuroimmunol 2008; 194: 54–61.
Fain JN . Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006; 74: 443–477.
Skurk T, Herder C, Kraft I, Muller-Scholze S, Hauner H, Kolb H . Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 2005; 146: 1006–1011.
Starnes T, Broxmeyer HE, Robertson MJ, Hromas R . IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol 2002; 169: 642–646.
Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C et al. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 2008; 117: 806–815.
Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277–2286.
Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007; 92: 2240–2247.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–1808.
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183: 2593–2603.
Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995; 155: 5483–5486.
Agrewala JN, Brown DM, Lepak NM, Duso D, Huston G, Swain SL . Unique ability of activated CD4+ T cells but not rested effectors to migrate to non-lymphoid sites in the absence of inflammation. J Biol Chem 2007; 282: 6106–6115.
Caspar-Bauguil S, Cousin B, Andre M, Nibbelink M, Galinier A, Periquet B et al. Weight-dependent changes of immune system in adipose tissue: importance of leptin. Exp Cell Res 2006; 312: 2195–2202.
Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007; 115: 1029–1038.
Csiszar A, Ungvari Z . Synergistic effects of vascular IL-17 and TNFα may promote coronary artery disease. Med Hypotheses 2004; 63: 696–698.
Csiszar A, Ungvari Z, Koller A, Edwards JG, Kaley G . Aging-induced proinflammatory shift in cytokine expression profile in coronary arteries. FASEB J 2003; 17: 1183–1185.
Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127: 89–97.
Hashmi S, Zeng QT . Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis 2006; 17: 699–706.
Acknowledgements
This study was supported by the Ministry of Science of the Republic of Serbia (Grants no. 145067, 145073 and 145003). We are immensely grateful to late Professor Vojin Sulovic for his kind support.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Sumarac-Dumanovic, M., Stevanovic, D., Ljubic, A. et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes 33, 151–156 (2009). https://doi.org/10.1038/ijo.2008.216
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2008.216
- Springer Nature Limited
Keywords
This article is cited by
-
Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors
Inflammopharmacology (2023)
-
Discrepancy in Metabolic Syndrome between Psoriatic Arthritis and Rheumatoid Arthritis: a Direct Comparison of Two Cohorts in One Center
Rheumatology and Therapy (2023)
-
Effects of Roux-en-Y gastric bypass on the metabolic profile and systemic inflammatory status of women with metabolic syndrome: randomized controlled clinical trial
Diabetology & Metabolic Syndrome (2023)
-
Study on the relationship between hormone and Lp(a) in Chinese overweight/obese patients
BMC Endocrine Disorders (2022)
-
Bacteroides ovatus-mediated CD27− MAIT cell activation is associated with obesity-related T2D progression
Cellular & Molecular Immunology (2022)